Tracon Pharmaceuticals, Inc.
TCONDelisted Jul 19, 2024- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001394319
Tracon Pharmaceuticals, Inc. was delisted on Jul 19, 2024; its insiders filed their last Form 4 on Mar 13, 2024; 29 institutions reported holding it in 13F filings for Q1 2024, worth $1.39M in total; no superinvestor held it.
13F holders, Q2 2022
Institutional positions in Tracon Pharmaceuticals, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 31
- −4 vs. Q1 2022
- Shares held
- 9.87M
- +740.3K (+8.1%) vs. Q1 2022
- Total value
- $19.7M
- −$4.27M (−17.8%) vs. Q1 2022
- New holders
- 2
- 7 more added
- Sold out
- 6
- 8 more reduced
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TCON on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 29 | $1.39M |
| Q4 2023 | 24 | $903.4K |
| Q3 2023 | 21 | $1.66M |
| Q2 2023 | 27 | $2.90M |
| Q1 2023 | 32 | $18.8M |
| Q4 2022 | 32 | $14.6M |
| Q3 2022 | 33 | $16.5M |
| Q2 2022 | 31 | $19.7M |
| Q1 2022 | 35 | $24.0M |
| Q4 2021 | 35 | $25.4M |
| Q3 2021 | 45 | $39.6M |
| Q2 2021 | 44 | $58.5M |
| Q1 2021 | 42 | $72.8M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Tracon Pharmaceuticals, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Simplex Trading, LLC | 256 | $0 | 0.00% | −10,714−97.7% | Reduced |
| TCI Wealth Advisors, Inc. | 300 | $1.00K | 0.00% | 00.0% | Unchanged |
| Truvestments Capital LLC | 318 | $1.00K | 0.00% | +318 | New |
| Cutler Group LP | 1,200 | $2.00K | 0.00% | −15,000−92.6% | Reduced |
| Wells Fargo & Company | 910 | $2.00K | 0.00% | +14+1.6% | Added |
| Tower Research Capital LLC (TRC) | 1,620 | $3.00K | 0.00% | +1,358+518.3% | Added |
| Group One Trading, L.P. | 3,600 | $7.00K | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 10,050 | $20.0K | 0.00% | −353−3.4% | Reduced |
| We Are One Seven, LLC | 11,780 | $24.0K | 0.00% | 00.0% | Unchanged |
| Hoylecohen, LLC | 13,000 | $26.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 17,337 | $35.0K | 0.00% | 00.0% | Unchanged |
| X-Square Capital, LLC | 17,973 | $36.0K | 0.02% | 00.0% | Unchanged |
| CSS LLC | 25,119 | $50.0K | 0.00% | −3,000−10.7% | Reduced |
| ACT Capital Management, LLC | 28,500 | $57.0K | 0.08% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 41,279 | $83.0K | 0.00% | −41,221−50.0% | Reduced |
| Dowling & Yahnke LLC | 47,455 | $95.0K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 52,600 | $105.0K | 0.00% | +23,400+80.1% | Added |
| Bank of New York Mellon Corp | 67,046 | $134.0K | 0.00% | −75,207−52.9% | Reduced |
| State Street Corp | 75,154 | $150.0K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 75,228 | $150.0K | 0.00% | +75,228 | New |
| Johnson & Johnson | 84,003 | $168.0K | 0.04% | 00.0% | Unchanged |
| Telemetry Investments, L.L.C. | 100,000 | $200.0K | 0.30% | +33,000+49.3% | Added |
| Geode Capital Management, LLC | 156,158 | $312.0K | 0.00% | +3,098+2.0% | Added |
| Two Sigma Advisers, LP | 160,500 | $321.0K | 0.00% | −48,500−23.2% | Reduced |
| Boothbay Fund Management, LLC | 268,301 | $537.0K | 0.02% | 00.0% | Unchanged |
| BlackRock Inc. | 305,410 | $611.0K | 0.00% | +5,789+1.9% | Added |
| NEA Management Company, LLC | 346,719 | $693.0K | 0.04% | 00.0% | Unchanged |
| Linden Advisors LP | 454,916 | $910.0K | 0.01% | 00.0% | Unchanged |
| Vanguard Group Inc | 590,688 | $1.18M | 0.00% | 00.0% | Unchanged |
| Ikarian Capital, LLC | 2,788,853 | $5.58M | 2.31% | −54,379−1.9% | Reduced |
| Opaleye Management Inc. | 4,125,322 | $8.25M | 3.72% | +970,224+30.8% | Added |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −49,743−100.0% | Sold out |
| Franklin Resources Inc | 0 | $0 | 0.00% | −43,700−100.0% | Sold out |
| Dimensional Fund Advisors LP | 0 | $0 | 0.00% | −19,563−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −4,828−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −4,000−100.0% | Sold out |
| Morgan Stanley | 0 | $0 | 0.00% | −1,940−100.0% | Sold out |